| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |